Our Digital Pathology applications includes:
- Multiplex detection of target expression
- Clinical trial and diagnostic support
- Broad portfolio of immuno-oncology biomarkers
Validated Assay – Production Ready
- Sensitivity
- Specificity
- Precision
- Concordance
- No Primary Antibody Control
- Cut Section Stability
Automated Quantitative Analysis (AQUA) of Biomarkers in Tumor
Our AQUA platform provides the quantitation of biomarkers per unit area based on pixels produced by fluorescent antibodies. This pathologist-developed solution was specifically designed to overcome subjective interpretation by the human eye.
Key benefits include:
- Standardized for clinical applications & supported by >100 publications
- Built under design control to enable companion diagnostics
- Exclusive ownership of patents and product offerings by Navigate
